References:
[1] Coronavirus disease 2019 (COVID-19) Situation Report – 79. World Health Organization. April 13, 2020
[2] M.Li, L. Chen, C. Xiong, X. Li .The ACE2 expression of maternal-fetal interface and fetal organs indicates potential risk of vertical transmission of SARS-COV-2. bioRxiv preprint doi: https://doi.org/10.1101/2020.02.27.967760.
[3] L. Anton , D.C. Merrill , L.A. Neves , et al., Activation of Local Chorionic Villi Angiotensin II Levels But Not Angiotensin (1-7) in Preeclampsia. Hypertension. 2008; 51(4):1066-72.doi: 10.1161/HYPERTENSIONAHA.107.103861.Epub 2008 Feb 7.
[4] Q.Lu, Y. Shi. Coronavirus disease (COVID‐19) and neonate: What neonatologist need to know. J Med Virol. 2020. doi: 10.1002/jmv.25740.
[5] L. Panahi, M. Amiri, S. Pouy. Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review. Arch Acad Emerg Med. 2020;8(1):e34. eCollection 2020
[6] S. Colaco, K. Chhbria, N. Singh et.al., Expression of SARS-CoV-2 receptor ACE2 and the spike protein processing enzymes in developing human embryos. arXiv:2004.04935 [q-bio.TO]
[7] R.R. Bhonde, U.V. Wagh. Susceptibility of human placenta to Japanese encephalitis virus in vitro. Indian J Med Res. 1985;82:371-3.
[8] R.S. Al-Lamki, J.R. Bradley, J.S. Pober. Human Organ Culture: Updating the Approach to Bridge the Gap from In Vitro to In Vivo in Inflammation, Cancer, and Stem Cell Biology. Front Med (Lausanne). 2017; 11(4):148. doi: 10.3389/fmed.2017.00148. eCollection 2017.